IN VITRO DIAGNOSTICS Mergers & Acquisitions HalioDx Qiagen NV Qiagen Marseille SA Management of Qiagen NV division Qiagen Marseille SA have formed a new company, HalioDx , through a buy-out
The cardiology sector has long been one of the most innovative in medtech, with technologies such as drug-eluting stents (DES) and transcatheter aortic valves cutting down the need for more invasive o
IN VITRO DIAGNOSTICS University of Oslo Inven2 AS Oslo University Hospital Oxford Gene Technology Ltd. Oxford Gene Technology licenses 12 cancer biomarkers from Inven2 Inven2 AS , the tech tr